HeartSciences Inc. Form 8-K Summary
Business Context and Reporting Period
HeartSciences Inc. (HSCS), an emerging growth company incorporated in Texas, filed this Current Report on Form 8-K on November 28, 2025. The filing discloses corporate governance actions regarding the company's equity incentive structure and executive compensation arrangements.
Key Financial Metrics
This filing does not contain financial statements, revenue figures, profit data, cash flow metrics, debt levels, or liquidity ratios. The document focuses exclusively on equity plan amendments and award grants.
Material Changes
- Equity Plan Amendment: The Board approved Amendment No. 3 to the 2023 Equity Incentive Plan, increasing the maximum aggregate number of shares available for issuance to 1,250,000 shares of Common Stock.
- Automatic Increase Mechanism: Starting with the fiscal year beginning May 1, 2026, the share pool will automatically increase annually to the lesser of 25% of total outstanding shares or a number determined by the Administrator.
- Shareholder Approval: The Plan Amendment is contingent upon shareholder approval at the next annual meeting.
Guidance, Outlook, and Unusual Items
Executive and Director Equity Awards: On November 28, 2025, the Board granted equity awards to key personnel under the amended plan:
- Andrew Simpson (CEO/Chairman): 70,000 restricted shares of Common Stock.
- Mark Hilz (COO/Secretary/Director): 45,000 Restricted Stock Units (RSUs).
- Danielle Watson (CFO): 15,000 RSUs.
- Non-Employee Directors: 15,000 RSUs each.
Vesting Conditions:
- Standard Vesting: Executive awards vest over three years (1/3 initially, then quarterly). Director awards vest over two years (1/2 initially, then quarterly).
- Performance Acceleration: All awards described above will immediately vest in full if the Company achieves $250,000 or more in revenue in any fiscal quarter ending after the report date.
- Change of Control: 100% of awards vest immediately upon a Change of Control.
- Termination Protection: Awards for Mr. Simpson and Mr. Hilz vest if terminated for any reason other than "Just Cause."
Investor Verification Checklist
- Verify the outcome of the shareholder vote required to approve the Plan Amendment at the next annual meeting.
- Monitor quarterly revenue reports to determine if the $250,000 threshold is met, which would trigger immediate vesting of all recent awards.
- Review the full text of Amendment No. 3 (Exhibit 10.1) for specific terms regarding the automatic annual share pool increase.
- Confirm the exact grant date and settlement timeline for the RSUs issued to executives and directors.